First image of the tested substance
First image of the tested substance
First image of the tested substance

Active ingredients and content

Methylphenidate

Quantity not determinable

Details of the substance tested

Thickness

Length x width

Diameter

Weight

Colour

White

Colour

Fracture groove

Relevant substance(s)

Methylphenidate (Ritalin®)

Learn more

Ketamine

Learn more

Risk assessment

This substance sold as ketamine does not contain ketamine, but methylphenidate (Ritalin).

Methylphenidate is mainly prescribed for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. Taking methylphenidate increases the concentration of the nerve messengers dopamine, noradrenaline and serotonin in the brain, which leads to a stimulating, energising and drive-enhancing effect.

As the spectrum of action of methylphenidate is relatively different from ketamine, there is a risk of overdosing. Higher doses of methylphenidate can lead to seizures, cardiac arrhythmia, headaches and confusion. Hallucinations can also be triggered at very high doses.

In the case of powders and crystalline samples, false declarations and impurities occur again and again; it is therefore essential to have these tested in a drug check before consumption!

Safer Use

Analysis

Have your substances tested in a Drug Checking

Testing

If you do not have the possibility to have substances analysed, always test a small amount to avoid overdoses.

Wait and see

Wait 2 hours after oral intake, as there are always powders / crystals in circulation with unexpected active ingredients, which can have a later onset of action.

Utensils

Always use your own sniffing utensils when applying powders nasally (sniffing) to avoid infecting yourself or others with diseases.

Similar warnings

Things to know